Results 131 to 140 of about 31,605 (218)

Cost-effectiveness of susceptibility-guided therapy under varying rates of clarithromycin resistance

The Lancet Regional Health. Western Pacific
Background: With resistance of Helicobacter polyri to antibiotics reaching alarming levels worldwide, the Maastricht VI/Florence consensus report recommended that susceptibility tests are routinely performed to improve cure rates, even before prescribing
Shihan Xu, Xianzhu Zhou, Yiqi Du
doaj   +1 more source

Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. [PDF]

Pathogens, 2023
Alarcón-Millán J, Bonilla-Delgado J, Fernández-Tilapa G, Nieto-Velázquez NG, Sierra-Martínez M, Alvarado-Castro VM, Cortés-Malagón EM.   +6 more
europepmc   +1 more source

Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41) [PDF]

, 2017
Objectives Antibiotic therapy of pulmonary Mycobacterium abscessus infection is based on a combination treatment including clarithromycin. Recent data demonstrated that M.
Bloemberg, Guido V., Böttger, Erik C., Maurer, Florian P., Ritter, Claudia, Rüegger, Vera   +4 more
core  

Quantitative multiplex real-time polymerase chain reaction assay for the detection of Helicobacter pylori and clarithromycin resistance. [PDF]

BMC Microbiol, 2023
Kim I, Maeng LS, Kim JS, Kim BW, Cheung DY, Kim JI, Park SH.   +6 more
europepmc   +1 more source

Consumption of antibiotics at St Luke’s Hospital : a critical factor behind the local prevalence of antimicrobial resistance? [PDF]

, 2006
The intensity of antibiotic use in hospital settings is recognised as possibly the most important factor for the selection of antimicrobial resistance. Hospitals are therefore being encouraged to undertake surveillance and benchmarking of antimicrobial ...
Borg, Michael Angelo, Zarb, Peter
core  

Real-Time Polymerase Chain Reaction for the Detection of Helicobacter pylori and Clarithromycin Resistance. [PDF]

Gut Liver, 2023
Noh JH, Ahn JY, Choi J, Park YS, Na HK, Lee JH, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JM.   +12 more
europepmc   +1 more source

Efficacy of 7-day Tailored Therapy for <i>Helicobacter pylori</i> Eradication based on Clarithromycin Resistance. [PDF]

Korean J Gastroenterol, 2023
Bae JH, Jo HH, Kwon JG, Kim EY.
europepmc   +1 more source

Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST [PDF]

, 2017
Objectives To assess the predictive value of in vitro drug susceptibility testing (DST) in slow-growing non-tuberculous mycobacteria (NTM), knowledge on quantitative levels of drug susceptibility should be available.
Böttger, Erik C., Friedel, Ute, Hombach, Michael, Lucke, Katja, Ritter, Claudia   +4 more
core  

Comparative molecular profiling of Helicobacter pylori infection and antibiotic genotypic resistance in paired gastric mucosa, gastric juice, and stool samples

Scientific Reports
Increasing antibiotic resistance in Helicobacter pylori (H. pylori) is undermining empirical eradication therapies. Non-invasive methods for resistance profiling are urgently needed to guide precision treatment.
Jianping Cheng, Chanjuan Fan, Xiaolin Zhao, Zhen Li, Dongling Xie, Yong Cai, Kun Huang, Mengyuan Yang, Hui Wang   +8 more
doaj   +1 more source

A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance. [PDF]

Intern Med, 2023
Adachi K, Kato S, Koshino A, Nagao K, Sugiyama T, Yoshimine T, Yamaguchi Y, Izawa S, Ohashi W, Ebi M, Funaki Y, Ogasawara N, Sasaki M, Kasugai K.   +13 more
europepmc   +1 more source